Avita Medical temporarily halts sales of Recell device in EU
Regenerative medicine firm Avita Medical has temporarily stopped the sales of Recell device in the Europe Union region.
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
04 Mar 19
Regenerative medicine firm Avita Medical has temporarily stopped the sales of Recell device in the Europe Union region.
28 Feb 19
SAM Medical, an industry leader in the pre-hospital, trauma care market, announced the availability of its new SAM…
21 Feb 19
A recently published multi-center, randomized, controlled trial (RCT) demonstrated higher rates of healing when using OASIS Wound Matrix…
19 Feb 19
Scientists have discovered new ways in which the body regulates blood clots, in a discovery which could one…
18 Feb 19
Copper 3D, using NASA funding, will tackle health problems that could affect astronauts in long-distance missions, such as…
04 Feb 19
StimLabs, a provider of regenerative technologies and products, has enrolled first patient in its trial designed to assess…
01 Feb 19
Advanced Medical Solutions Group has acquired Sealantis, a developer of alginate-based tissue adhesive technology platform, to enhance access…
23 Jan 19
Aether, a 3D bioprinting firm, has partnered with researchers from University College London (UCL) and Loughborough University for…
16 Jan 19
Medical device manufacturer medi USA announced the launch of its new ready-to-wear circaid juxtalite hd. The juxtalite hd…
14 Jan 19
Generex Biotechnology’s subsidiary Olaregen Therapeutix is planning commercial launch of three dosing options for Excellagen wound conforming gel…